Image Guided Radiation Therapy For Prostate Cancer

Sex: Male

Healthy volunteers: No

Phase: PHASE3

Enrollment: 470

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Summary

During the 7 to 8 weeks of conformal radiotherapy for prostate carcinoma, the prostate has an intra-pelvic motion which is not detectable by the conventional portal imaging. This prostate motion may lead to a mistargeting, which possibly decreases the local control. On the other hand, the new 3D on board imaging (3D OBI) allows to localize the target but is expensive. The cost/effectiveness ratio is not well established, as well as the frequency of using such imaging during the course of radiation.

Eligibility Criteria

Inclusion Criteria: * prostate adenocarcinoma * intermediate / high risk group * N0 or N - * treatment by conformal radiotherapy (including or not IMRT), with or without androgen deprivation Exclusion Criteria: * pelvic irradiation * metal objects in the pelvis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT00433706). StuddyBuddy aggregates publicly available trial information.